Kenox Pharmaceuticals Inc. and Lactiga US, Inc. are pleased to announce a strategic collaboration to advance the development of novel, groundbreaking, mucosal-targeted Secretory IgA (sIgA) therapies for immunodeficient patients. This partnership is supported by a significant multi-million-dollar STTR grant awarded to Lactiga by the National Institute of Allergy and Infectious […]
Trending News
Astellas and YASKAWA Agree to Establish a Joint Venture Focused on Cell Therapy Manufacturing
Astellas Pharma Inc. and YASKAWA Electric Corporation signed a definitive agreement to establish a joint venture for the development of a cell therapy product manufacturing platform utilizing the dual-arm robot “Maholo.” In addition, the joint venture will offer platform access to startups and academic institutions, fostering collaboration and innovation in […]
Wellvana acquires CVS Health’s MSSP business
Wellvana and CVS Health® (NYSE: CVS) today announced that Wellvana has acquired the Medicare Shared Savings Program (MSSP) business of CVS Accountable Care™, part of CVS Health, in an all-stock transaction, giving CVS Health a strategic minority investment in Wellvana. With the acquisition, Wellvana cements itself as one of the […]
MYndspan and MEGIN Partner to Make MEG Brain Scans More Accessible
MYndspan, a pioneer in consumer brain health technology, announced a new partnership today with MEGIN, the global leader in magnetoencephalography (MEG), to make high-precision brain scanning more widely available. This collaboration will allow MYndspan to introduce consumer-accessible MEG brain scans, beginning with its flagship location in London later this year. MEG stands out […]
Coreline Soft Leads AI Medical Imaging Innovation at STR 2025
Coreline Soft will demonstrate its cutting-edge AI-based lung and thoracic imaging solution lineup at the Society of Thoracic Radiology 2025 (STR) on March 1st. STR is an international academic event where global thoracic radiology experts share the latest research results and future technology trends. This year, AI technology related to lung and […]
HNL Lab Medicine Begins Subtyping Positive Flu A Samples for H5N1 Avian Influenza
In response to updated recommendations from the Centers for Disease Control and Prevention, HNL Lab Medicine will begin subtyping all positive influenza A samples from hospitalized patients to detect H5N1 Highly Pathogenic Avian Influenza. This enhanced surveillance effort is part of a broader initiative to monitor potential bird flu cases […]
Konstellate Launches Revolutionary New AI-Powered Platform for Pharma Decision-Makers That Transforms KOL Intelligence
Konstellate, a leading provider of AI technology to power Key Opinion Leaders (KOLs) intelligence for pharma decision-makers, announced today the launch of its new platform. It synthesizes KOL discussions across multiple digital formats to provide pharmaceutical companies with unparalleled insights never before available. The AI-powered platform, with the ability to […]
NeuralCure AI Announces Breakthrough in AI-Powered Healthcare, Completing Decades of Medical Research in Moments
NeuralCure AI, an emerging leader in AI-powered healthcare technology, today unveiled its groundbreaking platform capable of compressing a century of medical research into a single day. By leveraging AI-driven diagnostics and rapid treatment protocol simulations, NeuralCure AI is pioneering perfect-match treatment solutions that seamlessly integrate into research and patient care, […]
JEDMED and Otologic Technologies Announce Partnership to Launch the World’s First AI-Enabled Digital Otoscope
JEDMED Corporation, a global leader in advanced otoscopic solutions, and Otologic Technologies, developer of an artificial intelligence (AI)-driven diagnostic for ear diseases are proud to announce a groundbreaking partnership to deliver the world’s first AI-enabled digital otoscope. Otologic Technologies was founded by Dr. Aaron Moberly of Vanderbilt University Medical Center and Professor Metin Nafi Gurcan of Wake Forest University School […]
Selkirk Pharma Introduces ClinFAST to Expedite Fill/Finish for Clinical Trials
Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the launch of ClinFAST™, a paradigm-shifting service designed to assist clinical stage biotech and pharma companies with a rapid fill/finish process for clinical trial supplies. […]
